On one hand, MFAP4 deficiency reverses aortic constriction and isoproterenol-induced cardiac dysfunction without affecting cardiac hypertrophy in these models (Wang et al., 2020). This evidence concerns the gene MFAP4 and cardiac hypertrophy.